Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) – Research analysts at Piper Jaffray Companies upped their FY2019 earnings estimates for Allscripts Healthcare Solutions in a report issued on Tuesday, November 5th. Piper Jaffray Companies analyst S. Wieland now expects that the software maker will post earnings of $0.49 per share for the year, up from their previous forecast of $0.48. Piper Jaffray Companies also issued estimates for Allscripts Healthcare Solutions’ Q4 2019 earnings at $0.13 EPS, Q1 2020 earnings at $0.12 EPS, Q2 2020 earnings at $0.14 EPS, Q3 2020 earnings at $0.14 EPS, Q4 2020 earnings at $0.18 EPS, FY2020 earnings at $0.56 EPS, Q1 2021 earnings at $0.15 EPS, Q2 2021 earnings at $0.16 EPS, Q3 2021 earnings at $0.16 EPS and FY2021 earnings at $0.70 EPS.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its earnings results on Monday, November 4th. The software maker reported $0.17 EPS for the quarter, meeting analysts’ consensus estimates of $0.17. The company had revenue of $445.00 million during the quarter, compared to analysts’ expectations of $450.04 million. Allscripts Healthcare Solutions had a return on equity of 5.98% and a net margin of 12.00%. Allscripts Healthcare Solutions’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period last year, the business posted $0.18 EPS.

Several other brokerages have also recently issued reports on MDRX. BidaskClub upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Tuesday, September 24th. TheStreet upgraded Allscripts Healthcare Solutions from a “d+” rating to a “c-” rating in a research note on Friday, September 20th. Jefferies Financial Group assumed coverage on Allscripts Healthcare Solutions in a research note on Friday, August 23rd. They issued a “buy” rating and a $13.00 price objective for the company. Cantor Fitzgerald reiterated a “neutral” rating on shares of Allscripts Healthcare Solutions in a research note on Tuesday. Finally, Robert W. Baird set a $13.00 price objective on Allscripts Healthcare Solutions and gave the company a “buy” rating in a research note on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $11.75.

Shares of MDRX opened at $11.18 on Friday. The stock has a 50-day simple moving average of $10.84 and a 200-day simple moving average of $10.40. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.91 and a current ratio of 0.66. The stock has a market capitalization of $1.89 billion, a PE ratio of 20.33, a PEG ratio of 2.62 and a beta of 1.39. Allscripts Healthcare Solutions has a 1 year low of $8.54 and a 1 year high of $12.40.

Several institutional investors and hedge funds have recently made changes to their positions in MDRX. Glen Harbor Capital Management LLC lifted its stake in Allscripts Healthcare Solutions by 7.7% during the second quarter. Glen Harbor Capital Management LLC now owns 17,504 shares of the software maker’s stock worth $204,000 after purchasing an additional 1,248 shares during the last quarter. Tyers Asset Management LLC lifted its stake in Allscripts Healthcare Solutions by 7.7% during the second quarter. Tyers Asset Management LLC now owns 24,068 shares of the software maker’s stock worth $280,000 after purchasing an additional 1,716 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Allscripts Healthcare Solutions by 16.9% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,460 shares of the software maker’s stock worth $145,000 after purchasing an additional 1,800 shares during the last quarter. Riverhead Capital Management LLC lifted its stake in Allscripts Healthcare Solutions by 7.5% during the second quarter. Riverhead Capital Management LLC now owns 27,330 shares of the software maker’s stock worth $318,000 after purchasing an additional 1,900 shares during the last quarter. Finally, Flinton Capital Management LLC lifted its stake in Allscripts Healthcare Solutions by 7.7% during the second quarter. Flinton Capital Management LLC now owns 30,632 shares of the software maker’s stock worth $356,000 after purchasing an additional 2,184 shares during the last quarter.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Recommended Story: Penny Stocks

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.